| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.008 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.008 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.48 | 0.01 |